Pharmaceutical giant, Lupin Limited, has achieved a significant milestone by obtaining the US Food and Drug Administration (FDA)’s green light for its Abbreviated New Drug Application (ANDA) of Doxycycline Hyclate Delayed-Release Tablets USP in multiple doses. This nod from the FDA paves the way for Lupin to introduce a generic counterpart of the popular Doryx […]
Alembic Pharmaceuticals has bagged final approval from the US Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA) for Doxycycline Hyclate Delayed-Release Tablets USP in the strengths of 75 mg, 100 mg, 150 mg, and 200 mg. Doxycycline Hyclate Delayed-Release Tablets USP is Alembic Pharmaceuticals’ generic version of Doryx Tablets, 75 mg, […]
